Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
about
Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?HIV, Aging, and Viral Coinfections: Taking the Long View.Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in UgandaAlcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.Emerging challenges in managing hepatitis B in HIV patients.Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.Drug interactions in HIV-infected patients treated for hepatitis C.Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China.Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.Hepatitis B, hepatitis C and mortality among HIV-positive individuals.Human immunodeficiency virus and liver disease: A comprehensive update.Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.
P2860
Q26798469-1D3A4588-264E-4089-B9A2-09958FBB2106Q30245486-E620A9E8-05F4-4EE9-B6CA-F883EB088403Q33584371-F2697841-378E-428B-961C-AAAC82BA9962Q33787607-1FD8B62F-3785-4BF0-946A-3CAA71616566Q38296047-47EFE9A3-0E7F-4885-9EB1-8C8A687BB24FQ38544189-F82E0DD5-1890-40BF-8587-941BA25F3315Q38554604-507B0F7C-19E1-4768-8173-4BD5E0D54CA2Q38946506-BC3FB85A-9E89-4A72-9423-B4EEE7500BF0Q39414876-D00F07D7-AB19-4EF9-B557-4006AA306371Q40040535-3320919D-5E90-48A4-9144-904392924765Q40143109-7B1B6656-938A-45BC-A181-24487DF22D6FQ40332326-92D536B0-0F0A-4A5E-BC1B-7B0B192788F6Q40679543-B416A0E5-F687-4A2D-BF16-8CF215EABD99Q40989818-EDE4EDB1-AAF2-416C-9562-94D834BC25C6Q41934626-52C3E95F-801B-4D48-96FB-61B1E13331C3Q55109199-BDC93ABB-1DBA-444B-94AD-D47A3C0B4693Q55236948-F09030E3-53F8-4C43-B03E-D069FE04DEA2Q55698444-947E3B02-EED4-47EC-A980-C3E21B1E5ACD
P2860
Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hepatitis delta is a major det ...... eath in HIV-infected patients.
@en
Hepatitis delta is a major det ...... eath in HIV-infected patients.
@nl
type
label
Hepatitis delta is a major det ...... eath in HIV-infected patients.
@en
Hepatitis delta is a major det ...... eath in HIV-infected patients.
@nl
prefLabel
Hepatitis delta is a major det ...... eath in HIV-infected patients.
@en
Hepatitis delta is a major det ...... eath in HIV-infected patients.
@nl
P2093
P2860
P356
P1476
Hepatitis delta is a major det ...... eath in HIV-infected patients.
@en
P2093
Carmen de Mendoza
Eugenia Vispo
José Vicente Fernández-Montero
Pablo Barreiro
Pablo Labarga
Rocío Sierra-Enguita
P2860
P304
P356
10.1093/CID/CIU167
P407
P577
2014-03-14T00:00:00Z